Dr. Christopher Edward Kowalski, MD

Dr. Kowalski practices at Alaska Native Medical Center in Anchorage, Alaska, part of Alaska Native Tribal Health Consortium.

Dr. Kowalski's NPI, 1154761898, was assigned on June 26, 2013. Dr. Kowalski holds Alaska license 138336.

Dr. Kowalski's primary practice is Alaska Native Medical Center, at 4315 Diplomacy Dr, Anchorage, AK 99508 in Anchorage Borough. The practice phone is (907) 563-2662.

Dr. Kowalski's primary practice is Alaska Native Medical Center in Anchorage, Alaska, part of Alaska Native Tribal Health Consortium. The medical group on file is Alaska Native Medical Center. Dmand AI also links Dr. Kowalski to 4 more medical groups and 3 group practices and clinics, each named with a free account. Dr. Kowalski's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kowalski practices, 4 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Kowalski's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Kowalski is licensed in Alaska.

CMS data shows 80 Medicare services from Dr. Kowalski across 3 procedure codes in 2024, for 91 Medicare patients. Medicare paid $4,949 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 91 Medicare patients who saw Dr. Kowalski in 2024. The largest group is 65 to 74, with 44 patients. 74% of them have high blood pressure, and 53% have high cholesterol. 46% are also on Medicaid. Their average risk score is 1.04, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Kowalski's median patient age at 69, with 54% women.

In 2024, Dr. Kowalski wrote 109 Medicare Part D claims for 41 patients. 94% of them were for generic drugs. CMS names the drug for 84 of them, across 4 drugs with 11 or more claims each, at $1,052 in total drug cost. In 2023, CMS named 126 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Kowalski for performance year 2024, reported as part of a group. Dr. Kowalski accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 36 general payments to Dr. Kowalski from 8 drug and device companies from 2019 to 2023. Food and beverage make up the largest share, 100% of the total. Intersect ENT, Inc. paid the most, $642.